Skip to content

Goal-directed Labor Epidural Analgesia Maintenance

Programmed Intermittent Epidural Bolus vs. Continuous Epidural Infusion: a Multicenter, Pragmatic, Cluster-randomized Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05255263
Acronym
GLEAM
Enrollment
0
Registered
2022-02-24
Start date
2022-06-01
Completion date
2022-06-01
Last updated
2022-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Onset and Length Abnormalities

Keywords

Cesarean Delivery, Programmed Intermittent Epidural Bolus (PIEB), Continuous Epidural Infusion (CEI), Patient-Controlled Epidural Analgesia (PCEA), Normal Spontaneous Vaginal Delivery (NSVD), Instrumental Vaginal Delivery, Second Stage of Labor

Brief summary

The GLEAM trial is a multicenter, pragmatic, cluster-randomized trial to assess the effects of programmed intermittent epidural bolus versus continuous epidural infusion on the rate of spontaneous vaginal delivery and several other clinically-relevant outcomes.

Detailed description

BACKGROUND: The goal of Labor Epidural Analgesia (LEA) to provide optimal analgesia while limiting any impact on the course of labor. Until recently, the most common technique for epidural analgesia was a combination of continuous epidural infusion (CEI) and patient controlled epidural analgesia (PCEA). CEI delivers an infusion of local anesthetic into the epidural space at a constant rate. Programmed intermittent epidural bolus (PIEB)-a more recently-developed alternative to CEI-delivers intermittent boluses of local anesthetic into the epidural space at scheduled time intervals. A series of randomized control trials (RCT) have compared PIEB and CEI with overall results favoring PIEB for superior analgesia. However, CEI has been shown to be associated with an increased amount of local anesthetic consumption, which may increase the degree of motor blockade, placing parturients at higher risk for instrumental and cesarean deliveries. Studies to date have offered conflicting conclusions on whether CEI is associated with a reduced rates of normal spontaneous vaginal delivery (NSVD). AIM: The GLEAM trial aims to investigate the hypothesis that PIEB will have higher rates of NSVD than CEI. The effects of CEI vs. PIEB on cesarean delivery rate, instrumental vaginal delivery rate, length of second stage of labor, failed epidural rate. TRIAL DESIGN: Multi-center, pragmatic, cluster-randomized trial * Centers will be assigned to use either PIEB or CEI for the first-line labor epidural analgesia maintenance infusion for clusters of minimum one month duration * Participating institutions will be recruited via the Society for Obstetric Anesthesia and Perinatology (SOAP) Research Network * Centers must use an epidural solution with a low concentration of local anesthesia with an opioid. * Both PIEB and CEI must include PCEA - rates and volumes are determined by the institution * Neuraxial anesthesia can be initiated with Dural Puncture Epidural (DPE), Combined Spinal Epidural (CSE) or epidural bolus * Our sample will consist of all women, at least 18 years of age, who were admitted to the labour & delivery ward for planned vaginal delivery and had neuraxial analgesia * Data will be collected in routine clinical care and automatically extracted from the electronic health record (EHR) PARTICIPATING SITE CRITERIA: * Routinely provided LEA with Ropivacaine ≤ 0.125% or Bupivacaine ≤ 0.1% epidural solutions with fentanyl (1-3 mcg/ml) * Can provide LEA with PIEB or CEI * Must include PCEA as part of all LEA regardless of PIEB or CEI

Interventions

OTHERPIEB

Programmed Intermittent Epidural Bolus with Patient-Controlled Epidural Analgesia

OTHERCEI

Continuous Epidural Infusion with Patient-Controlled Epidural Analgesia

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Pragmatic, cluster-randomized, open-labeled, multiple-crossover trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Requests labor epidural analgesia requiring epidural maintenance with local anesthesia and opioid for planned vaginal delivery

Exclusion criteria

* Planned cesarean delivery * Planned operative vaginal delivery * Epidural time (placement to delivery) \< 1 hour

Design outcomes

Primary

MeasureTime frameDescription
Spontaneous Vaginal DeliveryDeliveryRate of Spontaneous Vaginal Delivery (Percent of total deliveries)

Secondary

MeasureTime frameDescription
Instrumental Vaginal DeliveryDeliveryRate of Instrumental Vaginal Delivery (Percent of total deliveries)
Length of Second StageDuring labor up to time of deliveryLength of Second Stage of Labor (hours)
Failed EpiduralDuring labor up to time of deliveryRate of Failed Epidural, requiring general anesthesia or epidural replacement. (Percent of total labor epidural anesthetics)
Local anesthetic concentrationDuring labor up to time of deliveryLocal anesthetic concentration (Percent solution)
Epidural opioids usedDuring labor up to time of deliveryEpidural opioid (identity of opioid)
Cesarean DeliveryDeliveryRate of Cesarean Delivery (Percent of total deliveries)
PIEB VolumeDuring labor up to time of deliveryProgrammed Intermittent Epidural Bolus Volume (mL)
PIEB IntervalDuring labor up to time of deliveryProgrammed Intermittent Epidural Bolus (minutes)
PCEA VolumeDuring labor up to time of deliveryPatient-Controlled Epidural Analgesia bolus volume (mL)
PCEA LockoutDuring labor up to time of deliveryPatient-Controlled Epidural Analgesia lockout time (minutes)
CEI rateDuring labor up to time of deliveryContinuous Epidural Infusion Rate (mL/hr)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026